Comparison of concurrent chemoradiation therapy with weekly cisplatin versus monthly fluorouracil plus cisplatin in FIGO stage IIB-IVA cervical cancer

Comparison of concurrent chemoradiation therapy with weekly cisplatin versus monthly fluorouracil plus cisplatin in FIGO stage IIB-IVA cervical cancer

Bibliographic Details
Main Authors:	Kong, Tae Wook, Chang, Suk-Joon, Paek, Jiheum, Yoo, Seung-Chul, Yoon, Jong-Hyuck, Chang, Ki-Hong, Chun, Mison, Ryu, Hee-Sug
Format:	Online
Language:	English
Published:	Korean Society of Gynecologic Oncology and Colposcopy 2012
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3469858/

Similar Items

Cost effectiveness of concurrent gemcitabine and cisplatin and radiation followed by adjuvant gemcitabine and cisplatin in stages IIB–IVA cervical cancer
by: Rajan, Narayan, et al.
Published: (2014)

Neoadjuvant and postoperative chemotherapy with paclitaxel plus cisplatin for the treatment of FIGO stage IB cervical cancer in pregnancy
by: Kong, Tae-Wook, et al.
Published: (2014)

Chemoradiation with cisplatin followed by either brachytherapy or radical hysterectomy. A non-randomized comparison in FIGO stages IB2-IIA
by: Cetina, Lucely, et al.
Published: (2007)

Epigenetic therapy with hydralazine and valproate associated to cisplatin chemoradiation in FIGO stage IIIB. A phase II study
by: Candelaria, Myrna, et al.
Published: (2007)

Concurrent Chemoradiation with Low-Dose Weekly Cisplatin in Locally Advanced Stage IV Head and Neck Squamous Cell Carcinoma
by: Kang, Myoung Hee, et al.
Published: (2015)

Phase I/II trial of 2-weekly docetaxel combined with cisplatin plus fluorouracil in metastatic esophageal cancer (JCOG0807)
by: Hironaka, Shuichi, et al.
Published: (2014)

Concurrent cisplatin and 5-fluorouracil versus concurrent cisplatin and docetaxel with radiotherapy for esophageal squamous cell carcinoma: a propensity score-matched analysis
by: Zhang, Peng, et al.
Published: (2016)

S-1 plus cisplatin versus fluorouracil plus cisplatin in advanced gastric or gastro-esophageal junction adenocarcinoma patients: a pilot study
by: Li, Yuhong, et al.
Published: (2015)

Locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiotherapy plus concurrent weekly cisplatin with or without neoadjuvant chemotherapy
by: Wee, Chan Woo, et al.
Published: (2015)

Successful Concurrent Chemoradiotherapy with Cisplatin plus Vinorelbine for Locally Advanced Thymic Carcinoma
by: Fukushima, Toshirou, et al.
Published: (2014)

Risk group criteria for tailoring adjuvant treatment in patients with endometrial cancer: a validation study of the Gynecologic Oncology Group criteria
by: Kong, Tae Wook, et al.
Published: (2015)

Concurrent chemoradiation with carboplatin for locally advanced cervical cancer at high-risk for developing cisplatin-induced renal dysfunction
by: Cetina, Lucely, et al.
Published: (2007)

Efficacy and safety of nedaplatin-based concurrent chemoradiotherapy for FIGO Stage IB2–IVA cervical cancer and its clinical prognostic factors
by: Fujiwara, Masateru, et al.
Published: (2015)

Effect of sorafenib on cisplatin-based chemoradiation in head and neck cancer cells
by: Möckelmann, Nikolaus, et al.
Published: (2016)

Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer
by: Wang, Jinwan, et al.
Published: (2015)

Concurrent cisplatin, continuous infusion fluorouracil and radiotherapy followed by tailored consolidation treatment in non metastatic anal squamous cell carcinoma
by: Zampino, Maria G, et al.
Published: (2011)

Hyperfractionated Radiotherapy with Concurrent Cisplatin/5-Fluorouracil for Locoregional Advanced Head and Neck Cancer: Analysis of 105 Consecutive Patients
by: Zaboli, David, et al.
Published: (2012)

Concurrent Chemoradiation for Vaginal Cancer
by: Miyamoto, David T., et al.
Published: (2013)

Modified Weekly Cisplatin-Based Chemotherapy Is Acceptable in Postoperative Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Cancer
by: Lu, Hsueh-Ju, et al.
Published: (2015)

Outcomes of esophagectomy after chemotherapy with biweekly docetaxel plus cisplatin and fluorouracil for advanced esophageal cancer: a retrospective cohort analysis
by: Yuji Akiyama, et al.
Published: (2018-07-01)

A Randomized Trial Comparing Cisplatin Plus 5-fluorouracil With or Without Levamisole in Operable Gastric Cancer
by: Choi, Jong Soo, et al.
Published: (1997)

Replacement of cisplatin with nedaplatin in a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma
by: Akiko Kuwahara, Motohiro Yamamori, Kohshi Nishiguchi, Tatsuya Okuno, Naoko Chayahara, Ikuya Miki, Takao Tamura, Tsubasa Inokuma, Yoshiji Takemoto, Tsutomu Nakamura, Kazusaburo Kataoka, Toshiyuki Sakaeda
Published: (2009-01-01)

Weekly etoposide, epirubicin, cisplatin, 5-fluorouracil and leucovorin: an effective chemotherapy in advanced gastric cancer.
by: Chi, K. H., et al.
Published: (1998)

S-1 plus cisplatin with concurrent radiotherapy versus cisplatin alone with concurrent radiotherapy in Chinese patients with nonsmall-cell lung cancer: A multicentre randomized controlled trial
by: Feng, Junfei, et al.
Published: (2016)

S-1 plus cisplatin with concurrent radiotherapy versus cisplatin alone with concurrent radiotherapy for stage III non-small cell lung cancer: a pilot randomized controlled trial
by: Yao, Lei, et al.
Published: (2015)

Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients
by: Mabuchi, Seiji, et al.
Published: (2017)

The comparison between weekly and three-weekly cisplatin delivered concurrently with radiotherapy for patients with postoperative high-risk squamous cell carcinoma of the oral cavity
by: Tsan, Din-Li, et al.
Published: (2012)

Comparison of Long-Term Survival and Toxicity of Cisplatin Delivered Weekly versus Every Three Weeks Concurrently with Intensity-Modulated Radiotherapy in Nasopharyngeal Carcinoma
by: Tao, Chang-Juan, et al.
Published: (2014)

Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for advanced gastric carcinoma.
by: Cho, Eun Kyung, et al.
Published: (2002)

Head and neck irradiation modulates pharmacokinetics of 5-fluorouracil and cisplatin
by: Hsieh, Chen-Hsi, et al.
Published: (2013)

Long term results of comparison of concurrent low-dose daily cisplatin versus the standard weekly cisplatin with six fractions per week radiotherapy in locally advanced head neck cancer
by: Gupta, Pramod Kumar, et al.
Published: (2016)

Concurrent chemoradiotherapy using paclitaxel plus cisplatin in the treatment of elderly patients with esophageal cancer
by: Song, Tao, et al.
Published: (2015)

External beam radiation plus concurrent intra-arterial chemotherapy with low dose cisplatin for muscle invasive bladder cancer
by: Matsumoto, Yoshihiro, et al.
Published: (2015)

Weekly nanoparticle albumin-bound paclitaxel in combination with cisplatin versus weekly solvent-based paclitaxel plus cisplatin as first-line therapy in Chinese patients with advanced esophageal squamous cell carcinoma
by: Wang, Hai-ying, et al.
Published: (2016)

Impact of concurrent chemotherapy on definitive radiotherapy for women with FIGO IIIb cervical cancer
by: Kuroda, Yuuki, et al.
Published: (2012)

Randomised phase II study of S-1/cisplatin plus TSU-68 vs S-1/cisplatin in patients with advanced gastric cancer
by: Koizumi, W, et al.
Published: (2013)

Nab-Paclitaxel in combination with Cisplatin Versus Docetaxel Plus Cisplatin as First-Line Therapy in Non-small Cell Lung Cancer
by: Yi Chen, et al.
Published: (2017-09-01)

Randomised phase II study of S-1/cisplatin plus TSU-68 vs S-1/cisplatin in patients with advanced gastric cancer
by: Koizumi, W, et al.
Published: (2014)

Daily Cisplatin and Weekly Docetaxel versus Weekly Cisplatin Intra-Arterial Chemoradiotherapy for Late T2-3 Tongue Cancer: A Pilot and Feasibility Trial
by: Yuichiro Hayashi, et al.
Published: (2018-07-01)

Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinoma
by: Fayette, Jérôme, et al.
Published: (2015)